scispace - formally typeset
Search or ask a question
Institution

American Cancer Society

NonprofitAtlanta, Georgia, United States
About: American Cancer Society is a nonprofit organization based out in Atlanta, Georgia, United States. It is known for research contribution in the topics: Cancer & Population. The organization has 1339 authors who have published 3700 publications receiving 688166 citations. The organization is also known as: American Cancer Society, ACS & American Society for the Control of Cancer.


Papers
More filters
Journal ArticleDOI
TL;DR: Men in the alcohol priming group drank significantly more than men in each of the other conditions, and, consistent with theory, men with histories of heavier drinking drank the most when primed with alcohol expectancies, indicating that expectancies can function as automatic memory processes.
Abstract: Studies showing that verbal priming can implicitly affect alcohol consumption have been used to support cognitive models of expectancies. However, because expectancy words reflect affective states as well as drinking outcomes, mediation through an affective pathway remains theoretically plausible (i.e., such words inadvertently may affect mood, which in turn influences drinking). The primary pathway was identified (and expectancy theory was tested) by comparing memory priming (using alcohol expectancy or neutral words) with mood induction (using positive or neutral music); an unrelated experiment paradigm allowed the priming manipulation to implicitly affect drinking. Men in the alcohol priming group drank significantly more than men in each of the other conditions, and, consistent with theory, men with histories of heavier drinking drank the most when primed with alcohol expectancies, indicating that expectancies can function as automatic memory processes.

127 citations

Journal ArticleDOI
James R. Cerhan1, Sonja I. Berndt2, Joseph Vijai3, Hervé Ghesquières4, James D. McKay5, Sophia S. Wang6, Zhaoming Wang2, Meredith Yeager2, Lucia Conde7, Paul I.W. de Bakker8, Alexandra Nieters9, David G. Cox, Laurie Burdett2, Alain Monnereau, Christopher R. Flowers10, Anneclaire J. De Roos11, Anneclaire J. De Roos12, Angela Brooks-Wilson13, Angela Brooks-Wilson14, Qing Lan2, Gianluca Severi15, Gianluca Severi16, Mads Melbye17, Mads Melbye18, Jian Gu19, Rebecca D. Jackson20, Eleanor Kane21, Lauren R. Teras22, Mark P. Purdue2, Claire M. Vajdic23, John J. Spinelli13, Graham G. Giles15, Graham G. Giles16, Demetrius Albanes2, Rachel S. Kelly24, Rachel S. Kelly25, Mariagrazia Zucca26, Kimberly A. Bertrand25, Anne Zeleniuch-Jacquotte27, Charles Lawrence28, Amy K. Hutchinson2, Degui Zhi29, Thomas M. Habermann1, Brian K. Link30, Anne J. Novak1, Ahmet Dogan3, Yan W. Asmann1, Mark Liebow1, Carrie A. Thompson1, Stephen M. Ansell1, Thomas E. Witzig1, George J. Weiner30, Amelie S. Veron, Diana Zelenika, Hervé Tilly, Corinne Haioun, Thierry Jo Molina31, Henrik Hjalgrim17, Bengt Glimelius32, Bengt Glimelius33, Hans-Olov Adami33, Hans-Olov Adami25, Paige M. Bracci34, Jacques Riby7, Martyn T. Smith7, Elizabeth A. Holly34, Wendy Cozen35, Patricia Hartge2, Lindsay M. Morton2, Richard K. Severson36, Lesley F. Tinker11, Kari E. North37, Nikolaus Becker38, Yolanda Benavente, Paolo Boffetta39, Paul Brennan5, Lenka Foretova, Marc Maynadie40, Anthony Staines41, Tracy Lightfoot21, Simon Crouch21, Alex Smith21, Eve Roman21, W. Ryan Diver22, Kenneth Offit3, Andrew D. Zelenetz3, Robert J. Klein3, Danylo J. Villano3, Tongzhang Zheng42, Yawei Zhang42, Theodore R. Holford42, Anne Kricker43, Jenny Turner44, Melissa C. Southey15, Jacqueline Clavel, Jarmo Virtamo45, Stephanie J. Weinstein2, Elio Riboli46, Paolo Vineis17, Rudolph Kaaks38, Dimitrios Trichopoulos25, Dimitrios Trichopoulos47, Roel Vermeulen8, Heiner Boeing, Anne Tjønneland, Emanuele Angelucci, Simonetta Di Lollo48, Marco Rais26, Brenda M. Birmann25, Francine Laden25, Edward Giovannucci25, Peter Kraft25, Jinyan Huang25, Baoshan Ma49, Baoshan Ma25, Yuanqing Ye19, Brian C.-H. Chiu50, Joshua N. Sampson2, Liming Liang25, Ju-Hyun Park51, Charles C. Chung2, Dennis D. Weisenburger6, Nilanjan Chatterjee2, Joseph F. Fraumeni2, Susan L. Slager1, Xifeng Wu19, Silvia de Sanjosé, Karin E. Smedby33, Gilles Salles52, Gilles Salles4, Christine F. Skibola7, Nathaniel Rothman2, Stephen J. Chanock2 
Mayo Clinic1, National Institutes of Health2, Memorial Sloan Kettering Cancer Center3, Centre national de la recherche scientifique4, International Agency for Research on Cancer5, City of Hope National Medical Center6, University of California, Berkeley7, Utrecht University8, University of Freiburg9, Emory University10, Fred Hutchinson Cancer Research Center11, Drexel University12, University of British Columbia13, Simon Fraser University14, University of Melbourne15, Cancer Council Victoria16, Statens Serum Institut17, Stanford University18, University of Texas MD Anderson Cancer Center19, Ohio State University20, University of York21, American Cancer Society22, University of New South Wales23, Public Health England24, Harvard University25, University of Cagliari26, New York University27, Westat28, University of Alabama at Birmingham29, University of Iowa30, University of Paris31, Uppsala University32, Karolinska Institutet33, University of California, San Francisco34, University of Southern California35, Wayne State University36, University of North Carolina at Chapel Hill37, German Cancer Research Center38, Icahn School of Medicine at Mount Sinai39, University of Burgundy40, Dublin City University41, Yale University42, University of Sydney43, Macquarie University44, National Institute for Health and Welfare45, Imperial College London46, Academy of Athens47, University of Florence48, Dalian Maritime University49, University of Chicago50, Dongguk University51, Claude Bernard University Lyon 152
TL;DR: Data provide substantial new evidence for genetic susceptibility to this B cell malignancy and point to pathways involved in immune recognition and immune function in the pathogenesis of DLBCL.
Abstract: Diffuse large B cell lymphoma (DLBCL) is the most common lymphoma subtype and is clinically aggressive. To identify genetic susceptibility loci for DLBCL, we conducted a meta-analysis of 3 new genome-wide association studies (GWAS) and 1 previous scan, totaling 3,857 cases and 7,666 controls of European ancestry, with additional genotyping of 9 promising SNPs in 1,359 cases and 4,557 controls. In our multi-stage analysis, five independent SNPs in four loci achieved genome-wide significance marked by rs116446171 at 6p25.3 (EXOC2; P = 2.33 × 10(-21)), rs2523607 at 6p21.33 (HLA-B; P = 2.40 × 10(-10)), rs79480871 at 2p23.3 (NCOA1; P = 4.23 × 10(-8)) and two independent SNPs, rs13255292 and rs4733601, at 8q24.21 (PVT1; P = 9.98 × 10(-13) and 3.63 × 10(-11), respectively). These data provide substantial new evidence for genetic susceptibility to this B cell malignancy and point to pathways involved in immune recognition and immune function in the pathogenesis of DLBCL.

126 citations

Journal ArticleDOI
TL;DR: Light and moderate physical activity including daily life activities were associated with lower endometrial cancer risk in the American Cancer Society Cancer Prevention Study II Nutrition Cohort, especially among women who are overweight or obese.
Abstract: Factors influencing circulating estrogen levels, insulin-mediated pathways or energy balance through obesity-related mechanisms, such as physical activity, have been proposed as potential risk factors for endometrial cancer. We examined measures of physical activity in relation to endometrial cancer risk in the American Cancer Society Cancer Prevention Study II Nutrition Cohort, a prospective study of cancer incidence and mortality, using information obtained at baseline in 1992. From 1992 to 2003, 466 incident endometrial cancers were identified among 42,672 postmenopausal women with intact uteri who were cancer-free at enrollment. Cox proportional hazards modeling was used to compute hazard rate ratios (RR) while adjusting for potential confounders. To assess the role of body mass index (BMI) in this relationship, we computed multivariate RR with and without adjustment for BMI and stratifying by BMI. All measures of physical activity and the avoidance of sedentary behavior were associated with lower endometrial cancer risk. Baseline recreational physical activity was associated with 33% lower risk (RR = 0.67, 95% CI 0.44–1.03 for 31.5+ vs. <7 MET-hr/week, trend p = 0.007) in the multivariate model without BMI. However, the trend was attenuated after further adjustment for BMI (trend p = 0.18). BMI significantly modified the association between physical activity and endometrial cancer risk (heterogeneity of trends p = 0.01). The inverse relationship was seen only among overweight or obese women (trend p = 0.003) and not in normal weight women (trend p = 0.51). In summary, light and moderate physical activity including daily life activities were associated with lower endometrial cancer risk in our study, especially among women who are overweight or obese. © 2008 Wiley-Liss, Inc.

126 citations

Journal Article
TL;DR: The 36% increase in risk associated with obesity among women who had never used postmenopausal estrogens may have important public health implications because obesity is a growing problem in the United States.
Abstract: Endogenous hormones may play a role in ovarian carcinogenesis. Postmenopausal obesity, although associated with higher circulating levels of estrogen and androgens, has not been linked consistently to ovarian cancer. The present study examined the relationship between body mass index (BMI), height, and ovarian cancer mortality among postmenopausal women in a large prospective mortality study of 300,537 women who were cancer free at enrollment in 1982 and had no history of hysterectomy or ovarian surgery. During 16 years of follow-up, 1,511 deaths occurred from ovarian cancer. Cox proportional hazard modeling was used to compute rate ratios (RRs) and to adjust for confounders. Ovarian cancer mortality rates were higher among overweight [BMI >/=25;RR, 1.16; 95% confidence interval (CI), 1.04-1.30] and obese women (BMI >/=30; RR, 1.26; 95% CI, 1.07-1.48) compared with women with BMI /=30) was limited to women who never used postmenopausal estrogens (RR, 1.36; 95% CI, 1.12-1.66) and was not seen among ever users (RR, 0.93; 95% CI, 0.62-1.41). Height was positively associated with ovarian cancer mortality. Compared with women 152-156 cm tall, ovarian cancer mortality rates were lowest for the shortest women (RR, 0.72; 95% CI, 0.47-1.10 for women /=177 cm). In this study, obesity and height appear to be independently associated with ovarian cancer mortality. The 36% increase in risk associated with obesity among women who had never used postmenopausal estrogens may have important public health implications because obesity is a growing problem in the United States.

126 citations

Journal ArticleDOI
TL;DR: The multidimensional aspects of the QOL of family caregivers of cancer survivors at 2 years after the diagnosis are characterized and certain aspects of caregivers' QOL by their demographic and caregiving characteristics are predicted.
Abstract: Purpose: Although a growing body of research has documented the quality of life (QOL) of cancer survivors beyond the initial phase of the survivorship, similar knowledge about family caregivers of cancer survivors remains limited. Thus, the current study aimed: (a) to characterize the multidimensional aspects of the QOL of family caregivers of cancer survivors at 2 years after the diagnosis and (b) to predict certain aspects of caregivers' QOL by their demographic and caregiving characteristics. Methods: A total of 1635 caregivers of cancer survivors participated in the nationwide Quality of Life Survey for Caregivers. Multidimensional aspects of QOL were assessed, including mental and physical health, as well as psychological adjustment and spirituality at 2 years post-diagnosis of their relatives' cancer. Results: Family caregivers reported normal levels of QOL after 2 years post-diagnosis, except that they were more likely to experience increased awareness of spirituality than do individuals who personally experience a chronic illness. In addition, caregivers' age and income and care-recipients' poor mental and physical functioning were significant predictors of their QOL at 2 years post-diagnosis. Conclusions: The findings suggest that younger, relatively poor caregivers who are providing care to relatives with poor mental and physical functioning may benefit from interventions to help in their spirituality and psychological and physical adjustment, 2 years after the initial cancer diagnosis. In addition, older, relatively poor caregivers may benefit from programs to reduce the physical burden of caregiving. These findings have implications for advancing public health research and practice. Copyright © 2009 John Wiley & Sons, Ltd.

126 citations


Authors

Showing all 1345 results

NameH-indexPapersCitations
Walter C. Willett3342399413322
Meir J. Stampfer2771414283776
Frank B. Hu2501675253464
David J. Hunter2131836207050
Edward Giovannucci2061671179875
Irving L. Weissman2011141172504
Bernard Rosner1901162147661
Susan E. Hankinson15178988297
Paolo Boffetta148145593876
Jeffrey A. Bluestone14351577080
Richard D. Smith140118079758
Garth D. Illingworth13750561793
Brian E. Henderson13771269921
Ahmedin Jemal132500380474
Michael J. Thun12939279051
Network Information
Related Institutions (5)
University of Texas MD Anderson Cancer Center
92.5K papers, 4.7M citations

89% related

Memorial Sloan Kettering Cancer Center
65.3K papers, 4.4M citations

89% related

Fred Hutchinson Cancer Research Center
30.9K papers, 2.2M citations

88% related

Mayo Clinic
169.5K papers, 8.1M citations

86% related

University of California, San Francisco
186.2K papers, 12M citations

85% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202312
20228
2021202
2020239
2019222
2018194